# Merck invests $57M in vaccine manufacturing expansion at Wilson plant

Merck announced a $57 million expansion of its vaccine manufacturing capabilities at its Wilson, North Carolina campus, adding 55 new jobs. The expansion is for production of the RotaTeq rotavirus vaccine.

- Type: Expansion
- Announced: 2019-12-04
- Where: Wilson, North Carolina, United States
- Value: $57.0M
- Jobs: 55
- Starts operating: Jul 2020
- Status: announced
- Products: RotaTeq rotavirus vaccine
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Merck](https://endata.com/companies/1841.md)

## Sources

- [wraltechwire.com](https://wraltechwire.com/2019/12/04/merck-to-invest-57m-add-more-jobs-at-wilson-vaccine-plant/), 2019-12-04: "Merck is delighted to announce its second significant investment at our Wilson plant in less than a year."
- [wilsontimes.com](https://www.wilsontimes.com/news/more-jobs-coming-to-merck-83015), 2019-12-05: "We'll be introducing a new manufacturing concept."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.